Delivery Order SPE2DB22D2206-SPE2DB25FDT49

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a medical product. The contract has a firm fixed price of $6,729.86 and a completion date of March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,655.81, is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The delivery order has a ceiling value of $22,034.25 and a completion date of December 26, 2024. The contract is a firm fixed-price type contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a ceiling value of $7,456.49 and a completion date of January 13, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $103,776.00 and is a firm fixed-price delivery order. It has an ultimate completion date of September 27, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,036.64, is for the procurement of BEYFORTUS 100 MG/ML syringes, a medical product. The contract is a firm fixed-price type with a period of performance through February 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $7,700.10 and a period of performance through October 2024. The contract is not designated as a set-aside and was awarded under firm fixed price pricing. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,854.85, is for the delivery of the medication BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of November 20, 2024 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $20,914.87 and a period of performance through March 7, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML medical products. The contract has a firm fixed price of $6,274.98 and an ultimate completion date of November 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDT49
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGE. The contract has a ceiling value of $10,675.53 and a period of performance through October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 and running through December 2025. The IDC enables DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. This particular delivery order does not have a set-aside designation.

Generated 1/10/25, 9:16 AM